Dr. Lin Sun-Hoffman is a patent attorney with a PhD in molecular biology/biochemistry. She has more than 20-year experience focusing on innovative life sciences client matters and she has handled all aspects of intellectual property matters, including the drafting and prosecution of patent applications, IP due diligence, opinion work, cross-board licensing transactions and technology transfers. She represents many innovative startup companiesas well as public companies.
Dr. Sun-Hoffman served as a patent examiner at the United States Patent and Trademark Office (USPTO), worked as in-house patent counsel for ABI (now Thermo Fisher) and Celera (now Quest), and did many years of government relations work for US non-profit organizations such as BIO and GMA (now Consumer Brands Association). Before entering into law, she did her postdoctoral work at National Cancer Institute at NIH. Dr. Sun-Hoffman holds JD from University of Maryland. She is licensed in Maryland and USPTO.
Dr. Sun-Hoffman serves as The Bayhelix Group Chapter Head in northern California; board member of Chinese Health Initiative based in Mountain View Ca; Advisor for Chinese Antibody Society; Secretary General of US-China Green Energy Council. She was President of the Chinese Bioscience Association in Silicon Valley in 2013, and President of the Chinese Biopharmaceutical Association (CBA-USA) 2008-2009; PTA executive council board of Palo Alto School District (2015-2017), and taught underprivileged students during
summer in rural area Yunnan China.